Trial Profile
Gallium-68 Prostate Specific Membrane Antigen (68Ga-PSMA) PET for Imaging of Thyroid Cancer: A Feasibility Study
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2021
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Thyroid cancer
- Focus Diagnostic use
- 25 Jun 2021 Status changed from recruiting to discontinued.
- 07 Jul 2020 Planned End Date changed from 31 Dec 2020 to 31 Dec 2021.
- 07 Jul 2020 Planned primary completion date changed from 1 Jun 2020 to 31 Dec 2021.